KevinMD.com: Social media’s leading physician voice
The KevinMD newsletterReal physician voices, twice a weekFree, and one click to unsubscribe.
Subscribe free →
NEWExperts by KevinMDPhysicians and health care experts, by specialty.Jill BeckerAddiction physicianFareeha SiddiquiHematologist-oncologistArnon KrongradSurgeonPaul HainPediatricianSally DaganzoInternistDayna IsaacsHematology-oncology fellowSteven E. WarrenLongevity physicianGretchen E. GreenDiagnostic radiologistAleksandra FilipovicMedical oncologistBobby DuboisInternistJoe PazonaUrologistPatricia De Marco CentenoPsychiatristAlan P. FerenRetired surgeonJeremy HeffnerTrauma surgeonDuane PenshornEmergency physicianHarvey CastroEmergency physicianLaurel A. CoonsScientistJamie PlattDiagnostics CEONathaniel AranaHealth care CEODana Y. LujanHealth care strategistBrowse experts

Another case of PML hits the MS drug Tysabri

Another case of PML hits the MS drug Tysabri

PML is a rare demylinating disease that occurs in 6 per 10 million patients. This is the third case that is associated with Tysabri. Investors are not happy.

Share this articleLinkedInFacebookXEmail

Tagged as: Patients

Real physician voices, twice a week

Free, and one click to unsubscribe.

No spam. We never share your email.

Keep reading

Latest on KevinMD →

Leave a Comment
KevinMD.com
Another case of PML hits the MS drug Tysabri